GlassScriptPhysician profile
Mayha Truong
NPI 1821010208
$2,870.64
in general payments reported to CMS, 2019-2025
19 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $380 · 2021: $516 · 2022: $494 · 2023: $531 · 2024: $345 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,104.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $841.50 | 2019-2023 | Xarelto |
| Pfizer INC. | $491.76 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $380.31 | 2019-2025 | Dificid, Verquvo, Zerbaxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.38 | 2021-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $163.47 | 2019-2023 | Eliquis |
| Novartis Pharmaceuticals Corporation | $157.54 | 2019-2024 | |
| Alexion Pharmaceuticals, INC. | $99.00 | 2021-2024 | Ultomiris |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.30 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.86 | 2019-2022 | |
| Aimmune Therapeutics, INC. | $69.15 | 2025 | Vowst |
| Vertex Pharmaceuticals Incorporated | $62.76 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $57.12 | 2019-2020 | |
| Shionogi INC | $46.20 | 2024 | Fetroja |
| Gilead Sciences, INC. | $42.26 | 2023-2024 | Veklury |
| La Jolla Pharmaceutical Company | $35.80 | 2024-2025 | Giapreza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher & Paykel Healthcare INC | $21.18 | 2021 | |
| Portola Pharmaceuticals, LLC | $14.01 | 2020 | |
| Allergan, INC. | $13.76 | 2019 | |
| Scpharmaceuticals INC. | $13.28 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayha Truong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.